Clinical Trials Browser

Phase 2 × Advanced Solid Tumor × camrelizumab × Clear all

NCT04282278 2021-12-10

Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor

Phase 2 Unknown

Other solid neoplasm

Advanced Solid Tumor